Translated from mRNA encoding tumor antigens at ribosomes, proteins are mainly presented by major histocompatibility complex class I (MHC I), which activate CD8+ T molecules and induce antitumor cellular immunity. The gene discussed is CD8A; the disease is neoplasm.